Stellate Ganglion Block (SGB) For Women for Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Hot FlushesHot Flashes
Interventions
DRUG

Bupivicaine

A computer-generated 1:1 block randomization scheme will be used to assign participants to receive bupivacaine. Randomization will be performed by the injectionist immediately before the injection procedure by opening an opaque envelope to reveal the participant number and group assignment printed on an index card.10 mL .5% bupivicaine will be administered.

DRUG

Saline

A computer-generated 1:1 block randomization scheme will be used to assign participants to receive saline. Randomization will be performed by the injectionist immediately before the injection procedure by opening an opaque envelope to reveal the participant number and group assignment printed on an index card. 5 mL sterile normal saline will be administered.

Trial Locations (1)

60611

Northwestern University Feinberg School of Medicine, Chicago

All Listed Sponsors
collaborator

University of Illinois at Chicago

OTHER

lead

Northwestern University

OTHER

NCT02513329 - Stellate Ganglion Block (SGB) For Women for Breast Cancer | Biotech Hunter | Biotech Hunter